CHMP2B and Alzheimer disease: It is interesting to note that we found CHMP2B immunoreactivity particularly in hippocampus and medial temporal lobe of 3-month-old Tg19959 mice before plaque pathology, the two areas that are the first to have GVD-affected neurons in AD [63].